feed,title,long_url,short_url
Benzinga,Minerva Seeks FDA Approval For Its Schizophrenia Candidate,https://benzinga.com/general/biotech/22/08/28587100/minerva-seeks-fda-approval-for-its-schizophrenia-candidate,https://bit.ly/3AESROk
Benzinga,Boosters Are Coming For Dangerous Omicron COVID-19 Variant. Here's Who May Be Rolling Them Out,https://benzinga.com/general/biotech/22/08/28586785/pfizerbiontech-seek-fda-emergency-use-nod-for-omicron-sub-variant-targeted-covid-19-shot,https://bit.ly/3KdDU99
Benzinga,Kronos Bio Starts Dosing In Early-Stage Leukemia Study With Next-Gen SYK Inhibitor,https://benzinga.com/general/biotech/22/08/28586802/kronos-bio-starts-dosing-in-early-stage-leukemia-study-with-next-gen-syk-inhibitor,https://bit.ly/3pCDm32
